NEW YORK – The most-read stories in 360Dx in 2022 ranged from stories about efforts to codify the US Food and Drug Administration's regulatory power over laboratory-developed tests to updates that companies gave at the JP Morgan Healthcare Conference to start the year. The most-read piece was about the fate of a once-touted diagnostic system from Cepheid that seemingly vanished into thin air. Below are the top stories that caught viewers' attention throughout 2022.
1) Highly Anticipated Cepheid Omni Point-of-Care System Falls Off Radar
2) FDA Control of LDTs Looms as Momentum Builds for VALID Act
3) JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
4) Roche Preparing New Diagnostic Product Launches for 2022 and Beyond
5) Sensitivity, Speed of Infection With Omicron Challenge COVID-19 Rapid Antigen Tests
6) JP Morgan Healthcare Conference Day 1: Qiagen, Adaptive Bio, Guardant Health, Natera, Sema4
7) BioMérieux to Acquire Antibiotic Susceptibility Test Firm Specific Diagnostics
8) FDA Warns Against Use of Three SARS-CoV-2 Rapid Antigen Tests
9) VALID Act Passes Out of Senate HELP Committee, But Potential Cracks in Support Appear
10) Diagnostics M&A Deals Skyrocket in 2021 as Companies Have COVID-19 Cash to Burn